B. Boneu

发表

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

The Performance of the Knowledge-Based System VALAB Revisited: An Evaluation after Five Years

J. Corberand, B. Boneu, P. Valdiguie, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions

D. Durand, B. Boneu, P. Sié, 1985, British journal of haematology.

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans.

C. Thalamas, B. Boneu, K. Sakariassen, 2000, Circulation.

FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE

M. Abbal, B. Boneu, J. Plante, 1975, The Lancet.

Platelet Survival Time (51CR) and Platelet Production Time (Aspirin-Mda Method): A Simultaneous Evaluation in Patients Affected with Cancers

B. Boneu, R. Bugat, A. Boneu, 1984 .

Platelet density analysis: a tool for the detection of acquired storage pool disease in man

B. Boneu, P. Sié, N. Eche, 1983, British journal of haematology.

Coulter Counter studies of hypotonic‐induced macrothrombocytosis in normal subjects and in idiopathic thrombocytopenic purpura patients

B. Boneu, P. Sié, C. Caranobe, 1982, British journal of haematology.

Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.

G. Laurent, B. Boneu, P. Sié, 2009, Scandinavian journal of haematology.

Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.

G. Laurent, B. Boneu, P. Sié, 2009, Scandinavian journal of haematology.

Platelet volume, density and 5 HT organelles (mepacrine test) in acute leukaemia.

B. Boneu, P. Sié, C. Caranobe, 2009, Scandinavian journal of haematology.

Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis?

B. Boneu, 2000, Thrombosis research.

Essential role of TGF‐β in the natural resistance to experimental allergic encephalomyelitis in rats

I. Bernard, A. Saoudi, B. Cautain, 2001, European journal of immunology.

Influence of Long Term Oral Anticoagulants upon Prothrombin Fragment 1 + 2, Thrombin-Antithrombin III Complex and D-Dimer Levels in Patients Affected by Proximal Deep Vein Thrombosis

B. Boneu, H. Boccalon, A. Elias, 1993, Thrombosis and Haemostasis.

D-Dimer Levels in Patients with Long-Term Antecedents of Deep Venous Thrombosis

B. Boneu, H. Boccalon, A. Elias, 1994, Thrombosis and Haemostasis.

Dermatan Sulfate Is a More Potent Inhibitor of Clot-bound Thrombin than Unfractionated and Low Molecular Weight Heparins

B. Boneu, H. Boccalon, D. Dupouy, 1994, Thrombosis and Haemostasis.

A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans.

C. Thalamas, B. Boneu, K. Sakariassen, 1998, Blood.

Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in flowing nonanticoagulated blood.

J. Ferrières, B. Boneu, K. Sakariassen, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture.

B. Boneu, J. Bascands, J. Girolami, 1999, Thrombosis research.

Pharmacokinetics and Tolerance of the Natural Pentasaccharide (SR90107/ORG31540) with High Affinity to Antithrombin III in Man

J. Necciari, G. Kieffer, B. Boneu, 1995, Thrombosis and Haemostasis.

A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbit

B. Boneu, C. Caranobe, D. Carrie, 1993, British journal of haematology.

The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.

J. Hirsh, M. Blajchman, B. Boneu, 1987, The Biochemical journal.

The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits.

J. Hirsh, B. Boneu, M. Buchanan, 1987, Thrombosis research.

Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties.

B. Boneu, M. Petitou, J. Choay, 1988, Thrombosis research.

Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatment

B. Boneu, H. Boccalon, P. Sié, 1991, British journal of haematology.

D-Dimer Test and Diagnosis of Deep Vein Thrombosis: A Comparative Study of 7 Assays

J. Cambus, B. Boneu, H. Boccalon, 1996, Thrombosis and Haemostasis.

A Randomised Trial of Subcutaneous Low Molecular Weight Heparin (CY 216) Compared with lntravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis

P. Prandoni, G. Agnelli, B. Blettery, 1991, Thrombosis and Haemostasis.

The role of the hematocrit in bleeding.

B. Boneu, F. Fernandez, 1987, Transfusion medicine reviews.

Delayed elimination of enoxaparine in patients with chronic renal insufficiency

J. Montastruc, G. Houin, B. Boneu, 1991 .

Low Molecular Weight Heparin Therapy: Is Monitoring Needed?

B. Boneu, 1994, Thrombosis and Haemostasis.

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies

B. Jude, J. Reny, C. Thalamas, 2005, Journal of thrombosis and haemostasis : JTH.

The pharmacodynamics of tinzaparin in healthy volunteers

G. Houin, J. Cambus, B. Boneu, 2002, British journal of haematology.

Cells: Role of Reactive Oxygen Species Tissue Factor Production by Mononuclear Polymorphonuclear Leukocytes Modulate

B. Boneu, Y. Cadroy, D. Dupouy, 2000 .

The Activity of Unfractionated Heparin and Low Molecular Weight Heparins in Rabbit Plasma – The Need for Using Absolute Anti-factor Xa and Antithrombin Activities

H. Hemker, S. Béguin, B. Boneu, 1997, Thrombosis and Haemostasis.

Plasminogen activator inhibitor in plasma is related to testosterone in men.

P. Caron, J. Louvet, R. Camare, 1989, Metabolism: clinical and experimental.

Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.

C. Thalamas, B. Boneu, K. Sakariassen, 2005, Thrombosis research.

Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals

A. Deal, M. Moia, S. Middeldorp, 2016, European journal of haematology.

Unfractionated Heparin and CY 216: Pharmacokinetics and Bioavailabilities of the Antifactor Xa and IIa Effects after lntravenous and Subcutaneous Injection in the Rabbit

G. Houin, L. Briant, B. Boneu, 1989, Thrombosis and Haemostasis.

Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of a low molecular weight heparin (CY 216) in normal and nephrectomized rabbits.

B. Boneu, P. Sié, C. Caranobe, 1985, Thrombosis research.

Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit

B. Boneu, P. Sié, Y. Cadroy, 1988, Seminars in thrombosis and hemostasis.

Anti‐thrombotic and haemorrhagic effects of active site‐inhibited factor VIIa in rats

P. Léger, J. Cambus, B. Boneu, 2001, British journal of haematology.

Pharmacokinetics of heparin and of dermatan sulfate: clinical implications.

B. Boneu, P. Sié, C. Caranobe, 1992, Advances in experimental medicine and biology.

AND OF DERMATAN SULFATE: CLINICAL IMPLICATIONS

B. Boneu, S. Saivin, C. Caranobe, 1992 .

3 Pharmacokinetics of heparin and low molecular weight heparin

B. Boneu, P. Sié, C. Caranobe, 1990 .

Pharmacodynamics of CY 216 in healthy volunteers: inter‐individual variations

J. Montastruc, G. Houin, B. Boneu, 1990, Fundamental & clinical pharmacology.

Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans.

J. Montastruc, G. Houin, B. Boneu, 1989, Blood.

Evidence for a saturable mechanism of disappearance of standard heparin in rabbits.

J. Hirsh, B. Boneu, M. Buchanan, 1987, Thrombosis research.

Heparin half‐life and sensitivity in normal subjects and in patients affected by deep vein thrombosis

B. Boneu, B. Eychenne, P. Sié, 1986, European journal of clinical investigation.

[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].

M. Clanet, B. Guiraud-Chaumeil, A. Rascol, 1982, Revue neurologique.

Delayed elimination of enoxaparin in patients with chronic renal insufficiency.

J. Montastruc, G. Houin, B. Boneu, 1991, Thrombosis research.

D-Dimers, Thrombin Antithrombin III Complexes and Prothrombin Fragments 1 + 2: Diagnostic value in Clinically Suspected Deep Vein Thrombosis

B. Boneu, H. Boccalon, P. Sié, 1991, Thrombosis and Haemostasis.

Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit

B. Boneu, P. Sié, C. Caranobe, 1990, British journal of haematology.

An IgM Lupus Anticoagulant that Neutralizes the Enhancing Effect of Phospholipid on Purified Endothelial Thrombomodulin Activity-A Mechanism for Thrombosis

J. Freyssinet, J. Cazenave, B. Boneu, 1986, Thrombosis and Haemostasis.

FACTOR VIII COMPLEX IN NORMAL PREGNANCY, PRE‐ECLAMPSIA AND FETAL GROWTH RETARDATION

B. Boneu, G. Pontonnier, A. Fournié, 1981, British journal of obstetrics and gynaecology.

An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.

J. Freyssinet, J. Dugoujon, G. Serre, 1991, The Journal of clinical investigation.

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

R. Tait, S. Schulman, A. Mumford, 2008, Thrombosis and Haemostasis.

How and when to monitor a patient treated with low molecular weight heparin.

B. Boneu, P. Moerloose, P. de Moerloose, 2001, Seminars in thrombosis and hemostasis.

Aging and Venous Thromboembolism Influence the Pharmacodynamics of the Anti-Factor Xa and Anti-thrombin Activities of a Low Molecular Weight Heparin (Nadroparin)

J. Necciari, B. Boneu, H. Décousus, 1998, Thrombosis and Haemostasis.

Pharmacokinetics of a low molecular weight heparin (Fraxiparine) in various stages of chronic renal failure.

G. Houin, B. Boneu, P. Sié, 1991, Nephron.

Pharmacokinetics of heparin and low molecular weight heparin.

B. Boneu, P. Sié, C. Caranobe, 1990, Bailliere's clinical haematology.

[Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].

B. Polack, J. Fiessinger, B. Boneu, 1989, La Revue de medecine interne.

Laboratory monitoring of low‐molecular‐weight heparin therapy—part II

B. Boneu, 2005, Journal of thrombosis and haemostasis : JTH.

Increased thrombosis incidence in a family with an inherited protein S deficiency and a high oxygen affinity hemoglobin variant

C. Négrier, B. Boneu, M. Dechavanne, 1994, American journal of hematology.

GROUP-SPECIFIC COMPONENT AND HIV INFECTION

D. Nixon, B. Boneu, C. Rizza, 1987, The Lancet.

Exercise-Induced Platelet Activation in Myocardial Infarction Survivors with Normal Coronary Arteriogram

P. Bernadet, J. Marco, B. Boneu, 1984, Thrombosis and Haemostasis.

An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.

B. Boneu, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Distribution of 16 hemostatic laboratory variables assayed in 100 blood donors.

B. Boneu, P. Sié, S. Saivin, 1990, Nouvelle revue francaise d'hematologie.

Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216.

G. Houin, B. Boneu, C. V. van Boeckel, 1994, Blood.

Antithrombotic properties of a dermatan sulfate hexadecasaccharide fractionated by affinity for heparin cofactor II.

B. Boneu, M. Petitou, P. Sié, 1993, Blood.

Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits

G. Houin, B. Boneu, M. Petitou, 1992, British journal of haematology.

Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.

G. Houin, B. Boneu, M. Petitou, 1990, The Journal of laboratory and clinical medicine.

Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits

B. Boneu, F. Ofosu, M. Petitou, 1988, Thrombosis and Haemostasis.

A Simple Method to Measure Dermatan Sulfate at Sub-Microgram Concentrations in Plasma

B. Boneu, P. Sié, D. Dupouy, 1988, Thrombosis and Haemostasis.

The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin

J. Hirsh, B. Boneu, F. Ofosu, 1985 .

Platelet Anti-Aggregating Activity and Tolerance of Clopidogrel in Atherosclerotic Patients

B. Boneu, G. Destelle, 1996, Thrombosis and Haemostasis.

Kinetics of technetium-labeled heparin in thromboembolism: preliminary report.

B. Boneu, J. Esquerré, R. Guiraud, 1979, International journal of nuclear medicine and biology.

The thrombomodulin/protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium.

B. Boneu, K. Sakariassen, P. Sié, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Low molecular weight heparin half life is prolonged in haemodialysed patients.

D. Durand, B. Boneu, P. Sié, 1986, Thrombosis research.

Placental transfer of glycosaminoglycans in the human perfused placental cotyledon model.

G. Houin, J. Dumas, B. Boneu, 1991, European journal of obstetrics, gynecology, and reproductive biology.

Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II.

B. Boneu, M. Petitou, J. Choay, 1988, Biochimica et biophysica acta.

Fatty Acids CycloOxygenase-1 Pathway : Beneficial Effect of Expression of Mononuclear Cells by the Arachidonic Acid Enhances the Tissue Factor

B. Boneu, Y. Cadroy, D. Dupouy, 1998 .

Pharmacokinetics and Pharmacodynamics of Intramuscular Dermatan Sulfate Revisited

G. Houin, J. Cambus, B. Boneu, 2003, Clinical drug investigation.

Platelet production time, uricemia, and some hemostasis tests in pre-eclampsia.

H. Grandjean, B. Boneu, P. Sié, 1980, European journal of obstetrics, gynecology, and reproductive biology.

Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre‐eclampsia

A. Berrebi, H. Grandjean, B. Boneu, 1993, British journal of obstetrics and gynaecology.

CONSTITUTIONAL HEPARIN CO-FACTOR II DEFICIENCY ASSOCIATED WITH RECURRENT THROMBOSIS

B. Boneu, P. Sié, D. Dupouy, 1985, The Lancet.

FACTOR-VIII COMPLEX FETAL GROWTH RETARDATION, AND TOXÆMIA

B. Boneu, G. Pontonnier, R. Bierme, 1977, The Lancet.

Up-regulation of tissue factor expression by platelet-derived growth factor in human vascular smooth muscle cells in culture--role of mitogen-activated protein kinase and effects of intracellular cyclic AMP.

B. Boneu, J. Xuereb, J. Constans, 1997, Thrombosis and haemostasis.

Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men.

C. Thalamas, B. Boneu, K. Sakariassen, 2001, Blood.

Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.

C. Thalamas, B. Boneu, K. Sakariassen, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Plasma antithrombins during heparin therapy.

B. Boneu, P. Sié, C. Caranobe, 1982, Thrombosis research.

Comparison of Anti‐Human and Anti‐Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia A

M. Torchet, M. Bertrand, B. Boneu, 1993, Vox sanguinis.

Nonfractionated Heparin Fails to Inhibit Arterial Thrombosis in a Human Ex Vivo Thrombosis Model

B. Boneu, K. Sakariassen, Y. Cadroy, 1999, Annals of vascular surgery.

A New Method for Quantifying Platelet Deposition in Flowing Native Blood in an Ex Vivo Model of Human Thrombogenesis

B. Boneu, K. Sakariassen, Y. Cadroy, 1998, Thrombosis and Haemostasis.

Heparin Reverses the Procoagulant Properties of Stimulated Endothelial Cells

B. Boneu, J. Lormeau, P. Sié, 1996, Thrombosis and Haemostasis.

Comparison of the fibrinolytic response to 10 minutes venous occlusion in males with and without antecedent of deep vein thrombosis.

B. Boneu, P. Sié, Y. Cadroy, 1991, Thrombosis research.

New antithrombotic agents for the prevention and treatment of deep vein thrombosis.

B. Boneu, 1996, Haemostasis.

Frequency of a defective response to activated protein C in patients with a history of venous thrombosis.

B. Boneu, P. Sié, Y. Cadroy, 1994, Blood.

Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216

G. Houin, B. Boneu, M. Petitou, 1994 .

Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effects.

G. Houin, B. Boneu, M. Petitou, 1992, The Journal of laboratory and clinical medicine.

Pharmacological Properties of a Low Molecular Weight Butyryl Heparin Derivative (C4-CY 216) with Long Lasting Effects

G. Houin, B. Boneu, M. Petitou, 1992, Thrombosis and Haemostasis.

M. Génestal, B. Boneu, P. Sié, 1982, Thrombosis and Haemostasis.

Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface

B. Boneu, K. Sakariassen, Y. Cadroy, 1994 .

Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface.

B. Boneu, K. Sakariassen, Y. Cadroy, 1994, Blood.

Preanalytical Recommendations of the ‘Groupe d’Etude sur l’Hémostase et la Thrombose’ (GEHT) for Venous Blood Testing in Hemostasis Laboratories

B. Polack, B. Boneu, J. Schved, 2001, Pathophysiology of Haemostasis and Thrombosis.

Effects of Heparin and Related Sulfated Polysaccharides on Tissue Factor Expression Induced by Mitogenic and Non-mitogenic Factors in Human Vascular Smooth Muscle Cells

J. Herbert, B. Boneu, J. Xuereb, 1999, Thrombosis and Haemostasis.

Reconstitution Of Liposomes Bearing Platelet Membrane Glycoproteins. A Functional Study With Von Willebrand Factor

B. Boneu, P. Sié, H. Chap, 1981, Thrombosis and Haemostasis.

Reconstitution of liposomes bearing platelet receptors for human von Willebrand factor.

B. Boneu, P. Sié, H. Chap, 1980, Biochemical and biophysical research communications.

Comparison of Anti-Human and Anti-Porcine Factor Vlll Inhibitor

M. Torchet, M. Bertrand, B. Boneu, 2009 .

Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species.

C. Legrand, F. Incardona, J. Maffrand, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Homozygous hemophilia A in a female.

B. Boneu, P. Sié, C. Caranobe, 1985, Thrombosis and haemostasis.

Serotonin uptake and storage in human platelet density subpopulations

B. Boneu, P. Sié, C. Caranobe, 1982, British journal of haematology.

Physiopathology of haemorrhagic syndrome related to ochratoxin A intoxication in rats.

P. Galtier, M. Alvinerie, B. Boneu, 1979, Food and cosmetics toxicology.

Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density.

B. Boneu, P. Sié, N. Eche, 2009, Scandinavian journal of haematology.

Further studies on the relationship between platelet buoyant density and platelet age

B. Boneu, A. Boneu, P. Sié, 1982, American journal of hematology.

Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.

B. Boneu, P. Sié, F. Fernandez, 1984, Thrombosis and haemostasis.

Malondialdehyde (MDS) re-appearance in human platelet density subpopulations after a single intake of aspirin.

B. Boneu, P. Sié, R. Bierme, 1980, Thrombosis research.

Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis.

B. Boneu, P. Sié, C. Caranobe, 1982, Thrombosis and haemostasis.

Heparin fractions with high and low affinities to antithrombin III are cleared at different rates.

B. Boneu, M. Petitou, M. Buchanan, 1986, Thrombosis research.

Pharmacokinetics of Heparin and Related Polysaccharides a

G. Houin, B. Boneu, P. Sié, 1989, Annals of the New York Academy of Sciences.

Pharmacokinetics of 125I-pentosan polysulfate in the rabbit.

G. Houin, J. Maffrand, B. Boneu, 1987, Thrombosis research.

Tolerance and Biological Activity of Pentosan Polysulfate After Intramuscular or Subcutaneous Administration for Ten Days in Human Volunteers

J. Thouvenot, B. Boneu, J. Albarède, 1986, Thrombosis and Haemostasis.

Guidelines of the French Society for Digestive Endoscopy (SFED)

C. Samama, D. Sautereau, T. Ponchon, 2006, Endoscopy.

Turnover Study of Heparin Cofactor II in Healthy Man

B. Boneu, P. Sié, J. Pichon, 1985, Thrombosis and Haemostasis.

Polymorphonuclear Leukocytes Modulate Tissue Factor Production by Mononuclear Cells: Role of Reactive Oxygen Species

B. Boneu, Y. Cadroy, D. Dupouy, 2000, The Journal of Immunology.

Comparison of Progressive Antithrombin Activity and the Concentration of Three Thrombin Inhibitors in Nephrotic Syndrome

M. Abbal, B. Boneu, F. Bouissou, 1981, Thrombosis and Haemostasis.

Plasma fibrinolytic activity in a group of hypogonadic men.

P. Caron, J. Louvet, J. Bazex, 1987, Scandinavian journal of clinical and laboratory investigation.

Arterial Thrombosis and Protein S Deficiency

J. Cazenave, B. Boneu, M. Wiesel, 1989, Thrombosis and Haemostasis.

Comparative Turn-Over of Heparin Cofactor II and Antithrombin III in Baboons Influence of Heparin and Pentosan Polysulfate Administration

B. Boneu, F. Lacheretz, P. Sié, 1986, Thrombosis and Haemostasis.

Neutralization of dermatan sulfate in vitro and in vivo by protamine sulfate and polybrene.

B. Boneu, P. Sié, C. Caranobe, 1989, Thrombosis research.

Inactivation of heparin cofactor II by polymorphonuclear leukocytes.

B. Boneu, P. Sié, D. Dupouy, 1987, Thrombosis research.

Effect of Pentosan Polysulphate Administration in Man on the Formation of Covalent Complexes Between Heparin Cofactor II and Thrombin Generated in Plasma by Contact Activation

B. Boneu, P. Sié, D. Dupouy, 1986, Thrombosis and Haemostasis.

Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.

J. Hirsh, B. Boneu, F. Ofosu, 1985, Thrombosis research.

Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides

B. Boneu, F. Ofosu, M. Petitou, 1986, British journal of haematology.

Exhausted platelets in patients with malignant solid tumors without evidence of active consumption coagulopathy.

B. Boneu, R. Bugat, A. Boneu, 1984, European journal of cancer & clinical oncology.

A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation.

J. Hirsh, B. Boneu, M. Buchanan, 1984, Thrombosis research.

Evidence that platelet density and volume are not related to aging.

B. Boneu, J. Plante, R. Bierme, 1977, Thrombosis research.

Independence of circadian rhythm of endogenous cortisol production and diurnal fluctuations of fibrinolysis in hospitalized patients

P. Caron, B. Boneu, P. Sié, 1994 .

to the Antithrombotic Effects of Heparin

J. Hirsh, B. Boneu, F. Ofosu, 2016 .

Effects of Heparin, Dermatan Sulfate and of their Association on the Inhibition of Venous Thrombosis Growth in the Rabbit

B. Boneu, C. Caranobe, A. M. Gabaig, 1992, Thrombosis and Haemostasis.

Antithrombotic and Bleeding Effects of a New Synthetic Direct Thrombin Inhibitor and of Standard Heparin in the Rabbit

J. Maffrand, B. Boneu, A. Bernat, 1987, Thrombosis and Haemostasis.

A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

J. Hirsh, G. Agnelli, B. Boneu, 1985, Circulation.

The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.

J. Hirsh, B. Boneu, F. Ofosu, 1985, Blood.

Pharmacokinetics of Dermatan Sulfate in the Rabbit After Intravenous Injection

G. Houin, B. Boneu, P. Sié, 1988, Thrombosis and Haemostasis.

Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1 and 2 during normal pregnancy

J. Goudemand, H. Grandjean, B. Boneu, 2003, British journal of haematology.

Efficacy and Safety of a Low-Molecular-Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

P. Prandoni, H. Vinazzer, B. Boneu, 1997, World Journal of Surgery.

Standard Heparin Enhances the Antithrombotic Activity of Dermatan Sulfate in the Rabbit but CY 216 Does Not

B. Boneu, M. Petitou, J. Choay, 1988, Thrombosis and Haemostasis.

Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbit.

G. Houin, B. Boneu, M. Petitou, 1992, Thrombosis research.

Aspirin and recurrent painful toes and fingers in thrombocythaemia.

B. Boneu, B. Guiraud, R. Bierme, 1972, Lancet.

Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.

B. Boneu, P. Sié, Y. Cadroy, 1992, Nouvelle revue francaise d'hematologie.

[Increase in mean platelet volume in shock-related thrombocytopenia].

N. Dastugue, M. Génestal, B. Boneu, 1982, La Nouvelle presse medicale.

High Titer Inhibitors in Severe Haemophilia A A Meta-analysis Based on Eight Long-term Follow-up Studies concerning Inhibitors Associated with Crude or Intermediate Purity Factor VIII Products

B. Boneu, H. Boccalon, A. Elias, 2005 .

The Expression of Tissue Factor and Tissue Factor Pathway Inhibitor in Aortic Smooth Muscle Cells Is Up-regulated in Synthetic Compared to Contractile Phenotype

B. Boneu, A. Terrisse, P. Sié, 2002, Thrombosis and Haemostasis.

Inhibition of Tissue Factor Synthesis by Disruption of ERK Kinases and PKC Signaling Pathways in Human Vascular SMCs

B. Boneu, J. Xuereb, J. Constans, 2000, Thrombosis and Haemostasis.

Quantitative evaluation of mepacrine labelled human platelet dense bodies in normals and in cases of peripheral thrombocytopenia.

B. Boneu, R. Bierme, C. Caranobe, 1978, Thrombosis research.

Arachidonic acid enhances the tissue factor expression of mononuclear cells by the cyclo-oxygenase-1 pathway: beneficial effect of n-3 fatty acids.

B. Boneu, Y. Cadroy, D. Dupouy, 1998, Journal of immunology.

A Comparative Study of the Anticoagulant and Antithrombotic Effects of Unfractionated Heparin and a Low Molecular Weight Heparin (Fraxiparine®) in an Experimental Model of Human Venous Thrombosis

B. Boneu, K. Sakariassen, R. Cariou, 1995, Thrombosis and Haemostasis.

Relationship between Endothelial Tissue Factor and Thrombogenesis under Blood Flow Conditions

K S Sakariassen, B. Boneu, K. Sakariassen, 1995, Thrombosis and Haemostasis.

Platelet alpha2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment

J. Montastruc, A. Rascol, M. Berlan, 1985, European journal of clinical investigation.

Laboratory investigations and prediction of thrombotic risk in polycythemia vera.

B. Boneu, 1994, Nouvelle revue francaise d'hematologie.

Predicting Daily Maintenance Dose of Fluindione, an Oral Anticoagulant Drug

J. Cambus, B. Boneu, H. Boccalon, 1996, Thrombosis and Haemostasis.

Pharmacological Properties of CY 216 and of Its ACLM and BCLM Components in the Rabbit

G. Houin, B. Boneu, S. Salvin, 1994, Thrombosis and Haemostasis.

Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.

K S Sakariassen, C. Thalamas, B. Boneu, 1999, Arteriosclerosis, thrombosis, and vascular biology.

La prise en charge des patients sous anticoagulants ou sous agents antiplaquettaires avant une endoscopie digestive

C. Samama, D. Sautereau, T. Ponchon, 2005, Acta Endoscopica.

The Effect of Platelet PlA Polymorphism on Experimental Thrombus Formation in Man Depends on Blood Flow and Thrombogenic Substrate

C. Thalamas, B. Boneu, K. Sakariassen, 2001, Thrombosis and Haemostasis.

Letter: Factor-VIII complex and endothelial damage.

M. Abbal, B. Boneu, J. Plante, 1975, Lancet.

Long‐haul flights do not activate hemostasis in young healthy men

C. Thalamas, J. Emmerich, B. Boneu, 2005, Journal of thrombosis and haemostasis : JTH.

Placental transport of low molecular weight heparin in the pregnant sheep

J. Hirsh, B. Boneu, M. Andrew, 1985, British journal of haematology.

Hemostasis, Prostacyclin and Preeclampsia.

B. Boneu, A. Fournié, 1982, Developmental Pharmacology and Therapeutics.

Enhancement of enzymatic fibrinolysis with 2‐MHz ultrasound and microbubbles

V. Larrue, P. Cintas, B. Boneu, 2004, Journal of thrombosis and haemostasis : JTH.

Anti-Thrombotic Effect of a Synthetic Heparin Mimetic in an Arterial Model of Thrombosis in Rats: Comparison with Unfractionated Heparin and Nadroparin

J. Herbert, P. Léger, J. Hérault, 2002, Thrombosis and Haemostasis.

Long‐term persistence of low‐molecular‐weight material with anti‐factor Xa activity contributes to anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbit

J. Herbert, J. Hérault, B. Boneu, 1997, Blood Coagulation and Fibrinolysis.

Comparison of the Antithrombotic Effects of Heparin, Hirudin and Clopidogrel according to the Nature of the Thrombogenic Surface in an Arterioarterial Shunt in Rats

M. Freund, J. Cazenave, P. Léger, 1999, Thrombosis and Haemostasis.

Strenuous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers.

D. Rivière, F. Pillard, C. Thalamas, 2002, Journal of applied physiology.

Evaluation of Some Platelet Parameters in a Group of Elderly People

B. Boneu, P. Sié, R. Bierme, 1981, Thrombosis and Haemostasis.

Platelet Density, 5 HT Organelles and Production Time in Chronic Arteritis of the Lower Limbs

B. Boneu, B. Pradère, P. Sié, 1980, Thrombosis and Haemostasis.

Pharmacodynamics and Tolerance of Two Nadroparin Formulations (10,250 and 20,500 Anti Xa IU·ml-1) Delivered for 10 Days at Therapeutic Dose

J. Necciari, J. Cambus, B. Boneu, 1998, Thrombosis and Haemostasis.

Platelet arachidonic acid metabolism in severe cerebrovascular disease.

A. Rascol, B. Boneu, B. Perret, 1982, Thrombosis research.

Comparison of three activated protein C resistance tests in the risk assessment of venous thrombosis in non-carriers of the factor V Leiden mutation

B. Boneu, C. Arnaud, P. Sié, 2006, Thrombosis and Haemostasis.

La prise en charge des patients sous anticoagulants ou sous agents antiplaquettaires avant une endoscopie digestive

C. Samama, T. Ponchon, G. Gay, 2008, Acta Endoscopica.

Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.

J. Cazenave, B. Boneu, Y. Sultan, 1988, Nouvelle revue francaise d'hematologie.

Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Royat Study Group.

P. Léger, B. Boneu, C. Arnaud, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Limitations of the chronometric assays to determine plasma antifactor Xa activity during low molecular weight heparin therapy.

B. Boneu, D. Pierrejean, A. Gabaig, 1991, Nouvelle revue francaise d'hematologie.

Glycosaminoglycans: Clinical Use

B. Boneu, 1996, Seminars in thrombosis and hemostasis.

Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.

B. Boneu, P. Sié, F. Fernandez, 1984, Thrombosis research.

Abnormal in Vivo Platelet Activation During Exercise in Patients with Effort Kyocardial Infarction and Normal Coronary Arteriogram

P. Bernadet, J. Marco, B. Boneu, 1983 .

Plasma fibrinolytic activity in a group of hypogonadic men.

P. Caron, J. Louvet, J. Bazex, 1987, Scandinavian journal of clinical and laboratory investigation.

Dipyridamole-aspirin versus low doses of heparin in the prophylaxis of deep venous thrombosis in abdominal surgery.

B. Boneu, C. Vaysse, J. Plante, 1979, Thrombosis research.